IDEAYA Biosciences, Inc. (IDYA:NASDAQ) closed at $31.83 on November 13, 2026, up 1.08% on the day. The stock trades 25.4% below its 52-week high of $42.68 and 18.7% above its 52-week low of $26.81. Over the past year, it lost 1.0%. IDEAYA Biosciences, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 13, 2025, IDYA closed higher on 122 days (48%). Its best day was June 8, 2026 (+11.28%) and its worst was June 9, 2026 (-10.83%). The stock moved 10% or more in a single session 2 times. It opened at least 5% above the previous day's high 2 times.
IDEAYA Biosciences Inc an oncology-focused medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, inhibitor for genetically-defined cancers having GNAQ or GNA11 gene mutations.
Find more stocks like IDYA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.